Definition, Differential & Clinical Hallmarks

Question	Answer
1. Define Neonatal Cholestasis Syndrome (NCS).	Neonatal cholestasis is defined as conjugated hyperbilirubinemia occurring within the first 3 months of life, fulfilling either of the following criteria: 1) Direct (conjugated) bilirubin $>1.0\text{ mg/dL}$ (when Total Bilirubin is $<5.0\text{ mg/dL}$). 2) Direct bilirubin $>20\%$ of Total Bilirubin (when Total Bilirubin is $\ge 5.0\text{ mg/dL}$). Clinically characterized by prolonged jaundice, high-colored urine staining diapers, pale/acholic stools, and hepatomegaly.
2. What is the most critical question when examining stool color in an infant with cholestasis?	The physician must personally inspect the infant's stool using a validated Infant Stool Color Card. - Categories 1, 2, and 3 are Abnormal / Acholic (white, chalky, putty-like, light yellow). - Categories 4, 5, and 6 are Normal / Pigmented (mustard yellow, brown, dark green). VIVA Pearl: Never rely on parental description! Parents frequently mistake urine-stained diapers for yellow stool.
3. How do you clinically and biochemically differentiate Extrahepatic Biliary Atresia (EHBA) from Idiopathic Neonatal Hepatitis (INH)?
4. What are the low-GGT cholestatic disorders in young infants?	Serum GGT is characteristically Normal or Low despite severe direct hyperbilirubinemia in: 1) Progressive Familial Intrahepatic Cholestasis Type 1 (PFIC-1 / Byler Disease) (ATP8B1 / FIC1 defect). 2) Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) (ABCB11 / BSEP defect). 3) Inborn Errors of Bile Acid Synthesis (BASD). 4) Arthrogryposis, Renal Dysfunction, Cholestasis (ARC) Syndrome (VPS33B mutation). (Contrast: GGT is markedly high in Biliary Atresia, Alagille syndrome, and PFIC-3).

Biliary Atresia: Diagnostics, Kasai Procedure & Pearls

Question	Answer
5. What is the "Triangular Cord Sign" on abdominal ultrasonography?	The Triangular Cord (TC) Sign is a triangular or tubular band-like echogenic fibrous thickening identified anterior to the bifurcation of the main portal vein on a high-resolution 4-hour fasting abdominal ultrasound. - Represents the fibrous ductal remnant of the extrahepatic biliary tree at the porta hepatis. - Thickness $\ge 4.0\text{ mm}$ has a sensitivity $>85\%$ and specificity $>98\%$ for Biliary Atresia.
6. Describe the role and preparation for Hepatobiliary Scintigraphy (HIDA Scan) in Biliary Atresia.	Radiotracers ($^{99m}\text{Tc-Mebrofenin}$ or $^{99m}\text{Tc-DISIDA}$) are injected intravenously: - Preparation: Must pre-treat the infant with Oral Phenobarbital at $5\text{ mg/kg/day}$ for 5 days prior to the scan (phenobarbital induces hepatic microsomal enzymes and maximizes canalicular bile excretion). - Diagnostic Finding: Normal prompt hepatic uptake of tracer, but COMPLETE ABSENCE of tracer excretion into the intestine at 24 hours confirms high-grade biliary tract obstruction (Biliary Atresia). If tracer enters the bowel, biliary atresia is definitively excluded.
7. What is the Kasai Portoenterostomy (Hepatoportoenterostomy)?	- Surgical Technique: Complete transection and excision of the atretic extrahepatic biliary fibrous remnant up to the vascular bifurcation at the porta hepatis, exposing microscopic patent bile ductules. Biliary drainage is reconstructed by fashioning a $40-50\text{ cm}$ Roux-en-Y jejunal loop anastomosed directly to the fibrous plate at the porta hepatis. - The 60-Day Golden Window: - Performed $<60\text{ days}$ of life: Bile drainage established in $>70-80\%$; long-term native liver survival $>50\%$. - Performed between $60-90\text{ days}$: Success rate drops to $40-50\%$. - Performed $>90\text{ days}$:** Success rate plummets to $<20-25\%$ due to irreversible secondary biliary cirrhosis.
8. What are the most common post-Kasai complications?	1) Ascending Bacterial Cholangitis: The most frequent complication ($50-70\%$ incidence), characterized by unexplained fever, worsening jaundice/acholic stools, and leukocytosis. Prevented by daily oral Cotrimoxazole or Neomycin prophylaxis for 6–12 months. 2) Progressive Portal Hypertension & Esophageal Varices: Due to ongoing intrahepatic biliary fibrosis despite bile drainage. 3) Anastomotic Stricture / Cessation of Bile Flow. 4) End-Stage Biliary Cirrhosis: Eventually requiring Liver Transplantation.
9. VIVA TRAP: What is Alagille Syndrome (Arteriohepatic Dysplasia) and what is its genetic basis?	Autosomal dominant condition caused by mutations in the JAG1 gene ($95\%$, chromosome 20p12) or NOTCH2 gene. Classic Pentad: 1) Hepatic: Paucity of interlobular bile ducts with high-GGT cholestasis and severe pruritus. 2) Cardiac: Peripheral Pulmonary Artery Stenosis (systolic murmur radiating to axillae) or Tetralogy of Fallot. 3) Skeletal: "Butterfly Vertebrae" on anterior-posterior chest/spine radiographs (failure of fusion of anterior vertebral arches). 4) Ocular: Posterior Embryotoxon (prominent Schwalbe's line on slit lamp). 5) Facies: Broad prominent forehead, deep-set hyperteloric eyes, straight nose, and pointed chin ("triangular facies").
10. Detail the Nutritional Management of an infant with Neonatal Cholestasis.	1) Medium-Chain Triglyceride (MCT) Formula: Formulate feeds where $50-70\%$ of fat calories come from MCTs (absorbed directly across enterocyte membranes into portal venous blood without requiring bile salt micellar incorporation). Target caloric intake: $130-150\text{ kcal/kg/day}$. 2) Water-Soluble Fat-Soluble Vitamins (ADEK Protocol): - Vitamin A: $5,000-10,000\text{ IU/day}$ orally. - Vitamin D3: $1,000-2,000\text{ IU/day}$ orally (or Calcitriol $0.05-0.2\text{ mcg/kg/day}$). - Vitamin E (TPGS): $15-25\text{ IU/kg/day}$ orally (TPGS forms water-soluble micelles independently of bile salts). - Vitamin K1: $2.5-5.0\text{ mg}$ orally 2-3 times/week or $1\text{ mg}$ IM monthly. 3) Choleretic Agent: Ursodeoxycholic Acid (UDCA) at $15-20\text{ mg/kg/day}$ divided bid.